E.G7-OVA [derivative of EL4 (see ATCC TIB-39)]

E.G7-OVA [derivative of EL4 (s

ee ATCC TIB-39)]
收藏
  • 询价
  • 2025年10月12日
    avatar
    14金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 技术资料
    • 物种来源

      小鼠

    • 是否是肿瘤细胞

      0

    • 运输方式

      冻存运输

    • 细胞类型

      T淋巴细胞

    • 品系

      C57BL/6N

    • 细胞形态

      淋巴样

    • 库存

      大量

    • 相关疾病

      淋巴瘤

    • ATCC Number

      CRL-2113™

    • 生长状态

      悬浮生长

    Designations: E.G7-OVA [derivative of EL4 (see ATCC TIB-39)]
    Depositors:  MJ Bevan
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Mus musculus
    Morphology: lymphoblast

    Source: Disease: lymphoma
    Strain: C57BL/6N
    Cell Type: T lymphocyte;
    Cellular Products: chicken ovalbumin
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Antigen Expression: H-2 b
    Comments: E.G7-OVA was derived in 1988 from the C57BL/6 (H-2 b) mouse lymphoma cell line EL4 (ATCC TIB-39 ).
    The EL4 cells were transfected by electroporation with the plasmid pAc-neo-OVA which carries a complete copy of chicken ovalbumin (OVA) mRNA and the neomycin (G418) resistance gene.
    E.G7-OVA cells contain a single copy of the inserted plasmid and synthesize and secrete OVA constitutively.
    C57BL/6 mice immunized with E.G7-OVA cells give rise to H-2 Kb restricted cytotoxic lymphocytes specific for the OVA 258-276 peptide.
    This cell line is a model system for studying major histocompatibility complex (MHC) class I restricted responses of cytotoxic T lymphocytes in mice.
    Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES and 1.0 mM sodium pyruvate and supplemented with 0.05 mM 2-mercaptoethanol and 0.4 mg/ml G418, 90%; fetal bovine serum, 10%
    Temperature: 37.0°C
    Subculturing: Medium Renewal: Every 2 to 3 days
    Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
    Preservation: Culture medium, 95%; DMSO, 5%
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    parental cell line:ATCC TIB-39
    References: 22630: Moore MW, et al. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785, 1988. PubMed: 3261634

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3000
    上海匹拓生物科技有限公司
    2025年12月04日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月16日询价
    ¥1280
    上海康朗生物科技有限公司
    2025年07月15日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月11日询价
    ¥3780
    上海圻明生物科技有限公司
    2025年07月14日询价
    E.G7-OVA [derivative of EL4 (see ATCC TIB-39)]
    询价